Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample
This cross-sectional study provides evidence that cannabis use is associated with poorer processing speed and working memory in pwMS, thereby presenting a possible additional risk factor for cognitive impairment. This finding takes on added concern in light of cannabis use increasing with its legalization, and the worldwide increase of cannabis potency.
Authors
- Anthony Feinstein (ORCID: https://orcid.org/0000-0002-0132-0909)
- Anne Kever (ORCID: https://orcid.org/0000-0002-3860-6839)
- Cecilia Meza (ORCID: https://orcid.org/0009-0002-8553-0440)
Institutions
- St. Michael's Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1111/ene.70142
- Citations
- 2
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.94